Watching Salarius Pharma; Zacks Small-Cap Research Sets $6.75 Price Target
Portfolio Pulse from Happy Mohamed
Zacks Small-Cap Research has set a price target of $6.75 for Salarius Pharmaceuticals. This could potentially influence the stock's performance in the short term.
July 11, 2023 | 5:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zacks Small-Cap Research has set a price target of $6.75 for Salarius Pharmaceuticals, which could potentially influence the stock's performance.
Price targets set by research firms often influence the market's perception of a stock. If the current price is below the target, it could create a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100